Unknown

Dataset Information

0

C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.


ABSTRACT: Among several genetic mutations known to cause amyotrophic lateral sclerosis (ALS), a hexanucleotide repeat expansion in the C9orf72 gene is the most common. In approximately 30% of C9orf72-ALS cases, 5-methylcytosine (5mC) levels within the C9orf72 promoter are increased, resulting in a modestly attenuated phenotype. The developmental timing of C9orf72 promoter hypermethylation and the reason why it occurs in only a subset of patients remain unknown. In order to model the acquisition of C9orf72 hypermethylation and examine the potential role of 5-hydroxymethylcytosine (5hmC), we generated induced pluripotent stem cells (iPSCs) from an ALS patient with C9orf72 promoter hypermethylation. Our data show that 5mC levels are reduced by reprogramming and then re-acquired upon neuronal specification, while 5hmC levels increase following reprogramming and are highest in iPSCs and motor neurons. We confirmed the presence of 5hmC within the C9orf72 promoter in post-mortem brain tissues of hypermethylated patients. These findings show that iPSCs are a valuable model system for examining epigenetic perturbations caused by the C9orf72 mutation and reveal a potential role for cytosine demethylation.

SUBMITTER: Esanov R 

PROVIDER: S-EPMC4761318 | biostudies-literature | 2016 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

C9orf72 promoter hypermethylation is reduced while hydroxymethylation is acquired during reprogramming of ALS patient cells.

Esanov Rustam R   Belle Kinsley C KC   van Blitterswijk Marka M   Belzil Veronique V VV   Rademakers Rosa R   Dickson Dennis W DW   Petrucelli Leonard L   Boylan Kevin B KB   Dykxhoorn Derek M DM   Wuu Joanne J   Benatar Michael M   Wahlestedt Claes C   Zeier Zane Z  

Experimental neurology 20151231


Among several genetic mutations known to cause amyotrophic lateral sclerosis (ALS), a hexanucleotide repeat expansion in the C9orf72 gene is the most common. In approximately 30% of C9orf72-ALS cases, 5-methylcytosine (5mC) levels within the C9orf72 promoter are increased, resulting in a modestly attenuated phenotype. The developmental timing of C9orf72 promoter hypermethylation and the reason why it occurs in only a subset of patients remain unknown. In order to model the acquisition of C9orf72  ...[more]

Similar Datasets

| S-EPMC4161616 | biostudies-literature
| S-EPMC4409587 | biostudies-literature
| S-EPMC7384305 | biostudies-literature
| S-EPMC3675239 | biostudies-literature
| S-EPMC5515847 | biostudies-other
| S-EPMC3711057 | biostudies-literature
| S-EPMC4344335 | biostudies-literature
| S-EPMC6557614 | biostudies-literature
| S-EPMC6737948 | biostudies-literature